TABLE 2.
Characteristics of study patients with a chart-confirmed CA-MRSA SSTI
| Characteristic | No. of patients positive (%)
|
|||
|---|---|---|---|---|
| Total (n = 84) | 2004 (n = 14) | 2005 (n = 27) | 2006 (n = 43) | |
| Age (yr) | ||||
| 0-10 | 13 (15) | 2 | 3 | 8 |
| 11-20 | 19 (23) | 4 | 5 | 10 |
| 21-50 | 41 (49) | 5 | 13 | 23 |
| >50 | 11 (13) | 3 | 6 | 2 |
| Male | 55 (66) | 9 (64) | 20 (74) | 26 (60) |
| Hospitalizeda | 39 (46) | 11 (79) | 8 (30) | 20 (47) |
| ß-Lactam therapyb | 57 (70)c | 12 (86) | 20 (77) | 25 (60) |
| Risk factor for CA-MRSAd | 17 (30) | 4 (33) | 6 (30) | 7 (28) |
a
Cultures were obtained at the time of admission or less than 48 h after admission.
b
P = 0.04, chi-square test for trend for decrease over the 3-year study period.
c
Data not available for two patients.
d
Among those receiving β-lactams.